Gujarat Fluorochemicals / Q2-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2025-11-07Back to FLUOROCHEM

Revenue

₹1,210 Cr

verified against source

Revenue YoY

2%

reported change

EBITDA

₹381 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
4 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY26: 344 · Positive source sentiment · 2025-07-15Q1 FY26Q2 FY26: 381 · Positive source sentiment · 2025-11-07Q2 FY26Q3 FY26: 283 · Negative source sentiment · 2026-02-12Q3 FY26Q4 FY26: 353 · Positive source sentiment · 2026-05-15Q4 FY26381283
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

GFL delivered a resilient Q2 FY26 with chemical segment revenue of ₹1,210 crore (+2% YoY), EBITDA of ₹381 crore (+26% YoY), and PAT of ₹198 crore (+51% YoY). EBITDA margin expanded 608 bps YoY to 32%, driven by better product mix and cost optimization. Fluoropolymer revenue grew 8% YoY but was impacted by US tariffs, while chlorochemicals declined 15% due to R22 reduction and seasonality. The battery materials business is progressing: LiPF6 prices surged from $10/kg to $17/kg, and the LFP CAM plant in India has been commissioned. Management expects revenue from EV materials to start in Q4 FY26 and targets 20,000 MT R32 capacity by March 2026. Key risk: US tariff uncertainty could delay fluoropolymer recovery and impact export margins.

Colored figures show movement against the previous available record.

Guidance to track

  • Management reaffirmed the target to achieve 20,000 MT R32 capacity by end of FY26, with plant restart expected by end of November 2025.
  • Revenue from EV materials business is expected to begin flowing from Q4 of the current financial year.
  • Management expects the battery chemicals business to reach EBITDA breakeven in FY27.
  • Capex for battery materials is expected to be around ₹1,500 crore in FY27, part of the ₹6,000 crore 4-5 year plan.

Risks flagged

  • Higher US tariffs have caused customers to delay buying decisions, impacting fluoropolymer sales. Management is exploring alternative markets but tariff persistence could weigh on growth.
  • A fire incident at the R32 plant has temporarily halted production. While management expects restart by end of November, any further delays could impact the 20,000 MT target.
  • Customer qualification for battery materials is a lengthy process. Management did not provide a specific timeline for commercial sales, creating uncertainty around revenue visibility.
  • Working capital days have increased to ~182 from 120 in FY22, partly due to inventory for export depots and EV samples. Management expects improvement only after full-scale operations.

Key quotes

  • We remain uniquely positioned as one of the only non-China integrated LIBS producers and are further expanding our capacities to capitalize on this opportunity.
  • The uncertainty emanating from the tariffs imposed by US impacted sales during the quarter which we expect to see easing off going forward.
  • We are fully funded for another up to $125 million which would be incurred over next say 6 to 9 months perhaps a year.

Research modules

Go one layer deeper.